Functional and molecular analyses of 10q deletions in human gliomas
Corresponding Author
Peter A. Steck
Department of Neuro-Oncology, The Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Department of Neuro-Oncology, Box 316, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.Search for more papers by this authorHuai Lin
Department of Neuro-Oncology, The Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Search for more papers by this authorLauren A. Langford
Division of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Search for more papers by this authorSamar A. Jasser
Department of Neuro-Oncology, The Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Search for more papers by this authorDimpy Koul
Department of Neuro-Oncology, The Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Search for more papers by this authorW.K. Alfred Yung
Department of Neuro-Oncology, The Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Search for more papers by this authorMark A. Pershouse
Department of Neuro-Oncology, The Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Search for more papers by this authorCorresponding Author
Peter A. Steck
Department of Neuro-Oncology, The Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Department of Neuro-Oncology, Box 316, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.Search for more papers by this authorHuai Lin
Department of Neuro-Oncology, The Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Search for more papers by this authorLauren A. Langford
Division of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Search for more papers by this authorSamar A. Jasser
Department of Neuro-Oncology, The Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Search for more papers by this authorDimpy Koul
Department of Neuro-Oncology, The Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Search for more papers by this authorW.K. Alfred Yung
Department of Neuro-Oncology, The Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Search for more papers by this authorMark A. Pershouse
Department of Neuro-Oncology, The Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Search for more papers by this authorAbstract
Extensive genomic deletions involving chromosome 10 are the most common genetic alteration in glioblastoma multiforme (GBM). To localize and examine the potential roles of two chromosome arm 10q tumor suppressor regions, we used two independent strategies: mapping of allelic deletions, and functional analysis of phenotypic suppression after transfer of chromosome 10 fragments. By allelic deletion analysis, the region of 10q surrounding the MMAC/PTEN locus was shown to be frequently lost in GBMs but maintained in most low-grade astrocytic tumors. An additional region at 10q25 containing the DMBT1 locus was lost in all grades of gliomas examined. The potential biological significance of these two regions was further assessed by examining microcell hybrids that contained various fragments of 10q. Somatic cell hybrid clones that retained the MMAC/PTEN locus have a less transformed phenotype with clones exhibiting an inability to grow in soft agarose. However, presence or absence of DMBT1 did not correlate with any in vitro phenotype assessed in our model system. These results support a model of molecular progression in gliomas in which the frequent deletion of 10q25–26 is an early event and is followed by the deletion of the MMAC/PTEN during the progression to high-grade GBMs. Genes Chromosomes Cancer 24:135–143, 1999. © 1999 Wiley-Liss, Inc.
REFERENCES
- Albarosa R, Colombo BM, Roz L, Magnani I, Pollo B, Cirenei N, Giani C, Conti AM, DiDonato S, Fincocchiaro G. 1996. Deletion mapping of gliomas suggests the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. Am J Hum Genet 58: 1260–1267. Medline
- Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JI, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D, Sidransky D. 1995. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genet 11: 210–212. Medline
- Cairns P, Okami K, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS, Sidransky D. 1997. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57: 4997–5000. Medline
- Cheney W, Johnson D, Vaillancourt M, Demers B, Avanzini J, Levy A, Dang U-C, Ramachandra M, Shabram P, Bolen JB, Tavtigian SV, Bookstein R. 1998. Suppression of tumorigenicity of U87MG glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res 58: 2331–2334. Medline
- Collins A, Frazer J, Teague J, Morton NE. 1996. A metric map of humans: 23,500 loci in 850 bands. Proc Natl Acad Sci USA 93: 14771–14775. Medline
- Davies MA, Lu Y, Sano T, Fang X, LaPushin R, Koul D, Bookstein R, Stokoe DF, Yung WKA, Mills GB, Steck PA. 1998. Adenoviral transgene expression of mmac/pten in human glioma cells inhibits akt activation and induces anoikis. Cancer Res (in press).
- Dowdy SF, Fasching CL, Araujo D, Lai K-M, Livanos E, Weissman BE, Stanbridge EJ. 1991. Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11. Science 254: 293–295. Medline
- Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV. 1995. Mutation of the MXI1 gene in prostate cancer. Nature Genet 9: 249–255. Medline
- Fults D, Pedone CA. 1993. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosomes Cancer 7: 173–177. Medline
- Fults D, Pedone CA, Thomas GA, White R. 1990. Allelotype of human malignant astrocytoma. Cancer Res 50: 5784–5789. Medline
- Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM. 1992. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52: 674–679. Medline
- Fults D, Pedone CA, Tompson GE, Uchiyama CH, Gumpper KL, Iliev D, Vinson VL, Tavtagian SV, Perry WL. 1998. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme. Int J Oncol 12: 905–910. Medline
- Furnari FB, Lin H, Huang HJS, Cavenee WK. 1997. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 94: 12479–12484. Medline
- Gray IC, Phillips SMA, Lee SJ, Neoptolemos JP, Weisssenbach J, Spurr NK. 1995. Loss of the chromosomal region 10q23–25 in prostate cancer. Cancer Res 55: 4800–4803. Medline
- Herbst RA, Weiss J, Ehnis A, Cavenee WK, Arden KC. 1994. Loss of heterozygosity for 10q22-qter in malignant melanoma progression. Cancer Res 54: 3111–3114. Medline
- James C, Carlbom E, Dumanski J, Hansen M, Nordenskjold M, Collins V, Cavenee W. 1988. Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546–5551. Medline
- Jen J, Harper W, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B. 1994. Deletion of p16 and p15 genes in brain tumors. Cancer Res 54: 6353–6358. Medline
- Karlbom AE, James CD, Boethius J, Cavenee WK, Collins VP, Nordenskjold M, Larsson C. 1993. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 92: 169–174. Medline
- Killary AM. Wolf ME, Giambernadi TA, Naylor SL. 1992. Definition of a tumor suppressor locus within chromosome 3p21-p22. Proc Natl Acad Sci USA 89: 10877–10881. Medline
- Kimmelman AC, Ross DA, Liang B. 1996. Loss of heterozygosity of chromosome 10p in human gliomas. Genomics 34: 250–254. Medline
-
Komiya A,
Suzuki H,
Ueda T,
Yatani R,
Emi M,
Ito H,
Shiazaki J.
1996.
Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer.
Genes Chromosomes Cancer
17: 245–253.
Medline
10.1002/(SICI)1098-2264(199612)17:4<245::AID-GCC6>3.0.CO;2-3 CAS PubMed Web of Science® Google Scholar
- Kon H, Sonoda Y, Kumabe T, Yoshimoto T, Sekiya T, Murakami Y. 1998. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas. Oncogene 16: 257–263. Medline
- Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943–1947. Medline
- Lin H, Bondy ML, Langford LA, Hess KR, Delclos GL, Wu X, Chan W, Pershouse MA, Yung WKA, Steck PA. 1998. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: Relationship to prognostic significance. Clin Cancer Res (in press).
- Louis DN, Gusella JF. 1995. A tiger behind many doors: Multiple genetic pathways to malignant glioma. Trends Genet 11: 412–415. Medline
- Maehama T, Dixon JE. 1998. The tumor suppressor, PTEN/MMAC1, dephophorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J Biol Chem 273: 13375–13378. Medline
- Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A, Poustka A. 1997. DMBT1, a new member of the SRCR superfamily on chromosome 10q25.3–26.1, is deleted in malignant brain tumours. Nature Genet 17: 32–39. Medline
- Murakami YS, Albertsen H, Brothman AR, Leach RJ, White RL. 1996. Suppression of the malignant phenotype of human prostate cancer cell line PPC-1 by introduction of normal fragments of human chromosome 10. Cancer Res 56: 2157–2160. Medline
- Myers MP, Tonks NK. 1997. PTEN: Sometimes taking it off can be better than putting it on. Am J Hum Genet 61: 1234–1238. Medline
- Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK. 1997. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94: 9052–9057. Medline
- Nakamura H, Yoshida M, Tsuiki H, Ito K, Ueno M, Nakao M, Oka K, Tada M, Kochi M, Kuratsu J, Ushio Y, Saya H. 1998. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region. Oncogene 16: 1009–1019. Medline
- Nihei N, Ichikawa T, Kawana Y, Kuramochi H, Kugo H, Oshimura M, Killary AM, Rinker-Schaeffer CW, Barrett JC, Isaacs JT, Shimazaki J. 1995. Localization of a metastasis suppressor gene (s) for rat prostatic cancer to the long arm of human chromosome 10. Genes Chromosomes Cancer 14: 112–119. Medline
- Pershouse MA, Stubblefield E, Hadi A, Killary AM, Yung WKA, Steck PA.. 1993. Analysis of the functional role of chromosome 10 loss in human glioblastoma. Cancer Res 53: 5043–5050. Medline
- Rasheed BK, Fuller GN, Friedman AH, Bigner DD, Bigner SH. 1992. Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes Cancer 5: 75–82. Medline
- Rasheed BK, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD, Bigner SH. 1995. Chromosome 10 deletion mapping in human gliomas: A common deletion region in 10q25. Oncogene 10: 2243–2246. Medline
- Rempel SA, Schwechheimer K, Davis RL, Cavenee WK, Rosenblum ML. 1993. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res 53: 2386–2392. Medline
- Roof DJ, Hayes A, Adamian M, Chishti AH, Li T. 1997. Molecular characterization of abLIM, a novel actin-binding and double zinc finger protein. J Cell Biol 138: 575–588. Medline
- Sonada Y, Murakami Y, Tominaga T, Kayama T, Yoshimota T, Sekiya T. 1996. Deletion mapping of chromosome 10 in human glioma. Jpn J Cancer Res 87: 363–367. Medline
- Steck PA, Hadi A, Cheong HC, Yung WKA, Pershouse MA. 1995. Evidence for two tumour suppressive loci on chromosome 10 involved in glioblastomas. Genes Chromosomes Cancer 12: 255–261. Medline
- Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV. 1997. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 15: 356–362. Medline
- Stubblefield E, Pershouse M. 1992. Direct formation of microcells from mitotic cells for chromosomal transfer. Somat Cell Mol Genet 18: 485–491. Medline
- Tsuda T, Marinetta MR, Masuelli L, Cutler ML. 1995. The ras suppressor RSU-1 localizes to 10p13 and its expression in the U251 glioblastoma cell line correlates with a decrease in growth rate and tumorigenic potential. Oncogene 11: 397–403. Medline
- von Deimling A, Louis DN, von Ammon K, Petersen I, Hoell T, Chung RY, Martuza R, Schoenfeld D, Yasargil MG, Wiestler OD, Seizinger BR. 1992. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma. J Neurosurg 77: 295–301. Medline
- Weshsler DS, Shelly CA, Petroff CA, Dang CV. 1997. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. Cancer Res 57: 4905–4912. Medline
- Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. 1987. Increased expression of epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899–6903. Medline